+ND Capital

153 Therapeutics

2048 Ventures

3B Future Health Ventures

3i Partners (Impact India Investment Partners LLC)

5AM Ventures

82VS

AbbVie

AbbVie Ventures

ABILITY Neurotech

Accequa

Acelot

Actinogen Medical Ltd.

Acurex Biosciences Corp.

adMare BioInnovations

age1 Fund I GP

AKIGAI AS

AlbionVC

Alithia Life Sciences Pty Ltd

Alkermes

Alpha Bronze

ALSA Ventures

Alta Companies

Ampleia

Andera Partners SA

Angelini Pharma S.p.A.

Angelini Ventures S.p.A.

Angels + Life.Sci Investors Network NJAngels.net

Anlong Medical Fund

Aperture Therapeutics

Apollo Health Ventures

Aqua Partners LLC

Aquillius Ventures

ARCH Venture Partners

Argobio Studio

Ariadne Bio

Arkitekt Ventures

ARPA-H

Arphamid Therapeutics GmbH

Arrowfield Capital

ASDERA LLC

Astellas Ventures Management LLC

Astrocyte Pharmaceuticals

atai Life Sciences N.V.

ATEM Capital

Autifony Therapeutics Limited

Avanzanite Bioscience B.V.

Avata Biosciences

Bank of America Merrill Lynch

Bayland Capital

Beacon Biosignals

Berkeley Frontier Fund

BERNINA BioInvest Ltd.

BioArctic AB

BioCentury Inc.

Biogen

Bioluminescence Ventures

Biovision Ventures

Bloom Science

BMO Capital Markets

Boehringer Ingelheim International GmbH

BOHE Angel Fund

Boston Consulting Group

Boxer Capital

Bpifrance Investment

Bradley Woods & Company

Brain Tx

BrainTale

Brenig Therapeutics Inc.

Breslin AG

Brookline Capital Markets

BROTHERS & Partners Europe

Bryan

BTIG

Canaccord Genuity LLC

Cannage Capital

CapsicoHealth

CaSRevolution S.r.l.

Catalytic Impact Foundation

CBT Advisors

Centre for Aging + Brain Health Innovation

Cilcare

Claris Ventures

Click Therapeutics

Cognition Therapeutics

Cognito Therapeutics

Cohesion Bureau

Collage Venture Partners LLC

Compass Pathways

Corundum Neuroscience

Crosswave Management

CTI Life Sciences

Cukierman & Co. Life Sciences

Cumulus Neuroscience

CuraSen Therapeutics

Cybin Inc.

D. Boral Capital

Daiichi Sankyo

Damona Pharma

David Fox Syndicate

Debere

Delix Therapeutics

DiademDx

DigitalDx Ventures

Dolby Family Ventures

Earlybird Venture Capital

EcoR1 Capital

Edison Group

EG 427

Eight Roads Ventures

Eikonizo Therapeutics

Eisai Innovation Inc.

Eli Lilly and Company

Endeavor Venture Fund

Engrail Therapeutics

Enveric Biosciences

EQT Life Sciences

ESC Advisors

EuMentis Therapeutics

Evexia Biofund

F. Hoffmann-La Roche Ltd.

Ferghana Partners

FieldLine Medical

Find Therapeutics

Focalpoint Partners

Forbion

Fortunatus Capital

Frazier Life Sciences

FreeMind Group

GAIA AG

Gain Therapeutics

Galimedix Therapeutics

Gate Neurosciences

GenEp

Generation Fund Life Sciences Fund I

Gilgamesh Pharmaceuticals

Gismo Therapeutics

Global Alzheimer's Platform Foundation

GOLDTRACK Ventures GmbH

Good Health Capital

GSK

GSKB Pharmaceuticals

H. Lundbeck A/S

H.C. Wainwright & Co.

Hanne Capital

HBM Partners AG

Health Innovation Capital

HEDA Ventures

Hestia Investments Ltd.

Hevolution

HighCape Capital

HighLight Capital

Hillhouse Investment Group

HMNC Holding GmbH

Hummingbird Ventures

Hydra Ventures (US) LLC

IAG Capital Partners

Iaso Ventures

ICF Consult Switzerland

ImmunoBrain Inc.

Indaco Venture Partners SGR S.p.A.

InflammaSense

Innovation Works

Innovestor Life Science Ltd.

Intermediate Capital Group PLC

InVivo Biosystems

IPF Partners

Ipsen

Ipsos Healthcare Advisory Service

JCR Pharmaceuticals Co.

Jefferies International Ltd.

Jifeng Ventures

JLS Fund II LP

Johnson & Johnson Innovation – JJDC

JT Pharma

Junson Capital

Kadima Neuropsychiatry Institute

Kaleida Capital

Kicker Ventures

Kurma Partners

Kynexis Therapeutics

Ladenburg Thalmann & Co. Inc.

Landmark Family Office/Landmark Angels

LDV Partners

Leerink Partners

LifeLink Ventures

Lifespan Vision Ventures

Lilly Asia Ventures

Lionheart Ventures

LMU Munich

Longevity Biotech

LSV Capital Partners

Lumanity

Lumira Ventures

Lundbeckfonden BioCapital

Lys Therapeutics

M Ventures

Magdalena Biosciences

Manifold Bio

MAPREG

Mass General Brigham Ventures

MedinCell S.A.

Merck Healthcare KGaA

Mid Atlantic Bio Angels

Mind Pharmaceuticals Corporation

MindMed

Mitsui & Co. Global Investment

Momentum Biotech

Monash Innovation - Preseed Fund

Morningside Venture Capital

MP Healthcare Venture Management

mpathic

MRL Ventures Fund

Myrobalan Therapeutics

National Institute of Neurological Disorders and Stroke

National Institute on Aging (NIA)

National Institutes of Health

Negev Capital Fund One

Negev Labs

Neurocentrx Pharma Ltd.

Neurotech Collider Lab

Neurotech Reports

Neurvati Neurosciences

New Harbor Venture Partners

New Science Fund

Nexa Bio Partners

Nexus NeuroTech Ventures

NFX

Nine Square Therapeutics

Nobias Therapeutics

Noble Capital Markets

Noble Equity Fund

Noema Pharma AG

Northern Light Venture Capital

NRx Pharmaceuticals

NSIP LLC

Nxera Pharma

ObserVa Capital / Simsan Ventures

Ontario Teachers Pension Plan

Oppenheimer & Co. Inc.

Oregon Venture Fund

Origami Therapeutics

Oryzon Genomics

Otsuka America Pharmaceutical

Otsuka Holdings Co.

Otsuka Pharmaceutical Co.

Oxford Finance

Palo Santo

Palo Santo VC

Panacea Venture

Panakès Partners SGR SpA

Pangea Botanica Ltd

Paramag Biosciences

Perceiv AI

Perceptive Advisors

PJT Partners

Plaisance Capital Management

Playground Global

Point6 Bio

Polaris Genomics

Praetego Inc

PremTara Ventures

Prevail Partners LLC

Pritzker Neuropsychiatric Disorders Research Consortium

Profound Ventures

ProNeurogen

Prudentia Sciences

Psilera Inc.

PsyMed Ventures Management

Qiming Venture Partners

Quan Capital

Raya Therapeutic

re.Mind Capital Ltd.

ReacX Pharmaceuticals

Real Endpoints

Relentless Venture Fund

Remiges Ventures

ReST Therapeutics SAS

Reunion Neuroscience

Robeauté

Robert W. Baird & Co. Inc.

Satori Neuro Partners LP

Sen-Jam Pharmaceutical

Serenatis Bio

Shadow Lake Group Inc.

Shanda Grab Ventures Limited

Shanghai Root Bioventure Capital Management Co. Ltd.

Silicon Valley Bank

Silicon Valley Venture Growth Partners

Sinaptica Therapeutics

Sixty Degree Capital

Snow Canyon Therapeutics

Solasta Ventures

Sony Ventures

Sound Bioventures

STALICLA SA

Stanford University

SternAegis Ventures

Strategic Transactions Advisory AG

SV Health Investors LLP

SWH2016 ApS

SynapCell

Tactile Therapeutics

Tailwinds Venture

Talu Ventures

TechWald Holding S.p.A.

Teitur Trophics ApS

The Benchmark Company

The Column Group

The Fulford Group Ltd.

The Global Emerging Markets Group

The MedTech Strategist / Bioscribe

The Michael J. Fox Foundation for Parkinson's Research

The Venture Collective

Tiberend Strategic Advisors

TMA Precision Health

Tonix Pharmaceuticals Holding Corp.

Transpacific Venture Capital Partners

Treo Ventures

TruVenturo GmbH

UCB Ventures

Unlearn.AI

V-Bio Ventures BV

Valor Management

VectorY Tx

Venture Valuation AG

Viscogliosi Brothers Watermark Holdings

Vivo Capital

WBB Securities

Wellington Management

Wellington Partners

Wells Fargo Securities

Wilson Hill Ventures

WISE SpA

WRF Capital

Wyss Center for Bio and Neuroengineering

Xnergy Financial

Xontogeny

Xylo Bio

Yorkville Advisors Global